Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Arsenic trioxide disturbs the LIS1/NDEL1/dynein microtubule dynamic complex by disrupting the CLIP170 zinc finger in head and neck cancer.

Authors: Gao, Lu; Xue, Bingye; Xiang, Bin; Liu, Ke Jian

Published In Toxicol Appl Pharmacol, (2020 09 15)

Abstract: Cancer mortality is mainly caused by metastasis, which requires dynamic remodeling of cytoskeletal components such as microtubules. Targeting microtubules presents a promising antimetastatic strategy that could prevent cancer spreading and recurrence. It is known that arsenic trioxide (ATO) is able to inhibit the migration and invasion of solid malignant tumors, but its exact molecular mechanism remains unclear. Here, we report a novel molecular target and antimetastatic mechanism of ATO in head and neck squamous cell carcinoma (HNSCC). We found that cytoplasmic linker protein 170 (CLIP170) was overexpressed in HNSCC tissues and cells compared to normal controls. ATO at non-cytotoxic level (1 μM) inhibited the migration and invasion of HNSCC cells by displacing zinc in the zinc finger motif of CLIP170, which is a key protein that controls microtubule dynamics. The antimetastatic effects of ATO were equivalent to those of siRNA-mediated CLIP170 knockdown. Furthermore, ATO dysregulated microtubule polymerization via the CLIP170/LIS1/NDEL1/dynein signaling pathway in Cal27 cells as a functional consequence of CLIP170 zinc finger disruption. The effect was partially reversed by zinc supplementation. Taken together, these findings reveal that CLIP170 is a novel molecular target of ATO and demonstrate the capability and underlying mechanisms of ATO as a potential antimetastatic agent for HNSCC treatment.

PubMed ID: 32717241 Exiting the NIEHS site

MeSH Terms: 1-Alkyl-2-acetylglycerophosphocholine Esterase/genetics; 1-Alkyl-2-acetylglycerophosphocholine Esterase/metabolism*; Adult; Arsenic Trioxide/pharmacology*; Carrier Proteins/genetics; Carrier Proteins/metabolism*; Cell Cycle/drug effects; Cell Line, Tumor; Cell Movement/drug effects; Dyneins/genetics; Dyneins/metabolism*; Female; Gene Expression Regulation, Neoplastic/drug effects; Head and Neck Neoplasms/metabolism*; Humans; Male; Microtubule-Associated Proteins/genetics; Microtubule-Associated Proteins/metabolism*; Microtubules; Middle Aged; Neoplasm Proteins/genetics; Neoplasm Proteins/metabolism*

to Top